Skip to content

Clinical trials

Phase 1 Migraine Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 1 Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20075
200811
20091
20102
20113
20125
20134
20145
20154
20166
20178
20186
20196
20202
20215
20222
20237
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Unknown status6
Terminated5
Recruiting3
Withdrawn3
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
Amgen7
Pfizer7
Merck Sharp & Dohme LLC6
H. Lundbeck A/S4
Yale University3
Zosano Pharma Corporation3
Acorda Therapeutics2
Alder Biopharmaceuticals, Inc.2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders94
Headache8
Migraine with Aura3
Migraine without Aura3
Back Pain2
Fibromyalgia2
Hypertension2
Inflammation2
Pain2
Stroke2

Trials

Showing 26 to 50 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.